Toxin-secreting gut bacterium emerges as a driver of ulcerative colitis

	Gastroenterology
	The latest gastroenterology‎ news from News Medical

	Toxin-secreting gut bacterium emerges as a driver of ulcerative colitis A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new treatment strategies.

	Study compares GLP-1 drug benefits and finds substantial variation in clinical effects GLP-1 receptor agonists improve glycaemic control and provide renal, metabolic, and selective cardiovascular benefits in people with type 2 diabetes, based on an umbrella review of 17 meta-analyses. However, these agents consistently increase gastrointestinal adverse effects and show important distinctions between class-level outcomes and individual drug effects, particularly for semaglutide.

			Study clarifies why most colic isn’t caused by cow’s milk allergy Cow’s milk allergy rarely causes infant colic on its own, and most excessively crying infants do not have underlying allergy. A short elimination–and–rechallenge trial may help confirm CMA only when colic coexists with other allergic features.

			Study shows gluten sensitivity is driven by gut–brain interactions rather than gluten A landmark study has revealed that gluten sensitivity, which affects approximately 10 per cent of the global population, is not actually about gluten but part of the way the gut and brain interact.

			Innovative new tool helps understand how gut microbes interact to influence health The gut microbiome is made up of trillions of microbes that play a vital role in keeping us healthy. A disturbance in the balance of these microbes can contribute to a variety of health conditions, such as inflammatory bowel disease (IBD).

	AGA issues updated guidance for pharmacologic treatment of moderate-to-severe Crohn's disease The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease.

	Experts launch digital hub to transform bowel cancer prevention and care World-leading experts have launched an online platform to enable the public to shape the future of bowel cancer research and patient care.

	Oral microsphere pills can detect markers of gastrointestinal disease Move over, colonoscopies - researchers report in ACS Sensors that they've developed a sensor made of tiny microspheres packed with blood-sensing bacteria that detect markers of gastrointestinal disease.

	New prognostic tool can predict transplant needs in drug-induced liver injury patients A newly developed tool, called the DILI-Inpt prognostic score, can predict patients with drug-induced liver injury who are unlikely to survive without a liver transplant.

	What Is Angelica Root? Benefits, Nutrition, and How It Supports Women’s Health Discover how traditional angelica root is being reshaped by modern research, revealing promising but still emerging benefits for inflammation, circulation, mood, and women’s hormonal health.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025